MEZLOCILLIN: 24 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
24
Total FAERS Reports
10 (41.7%)
Deaths Reported
13
Hospitalizations
24
As Primary/Secondary Suspect
1
Life-Threatening
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available
Active Ingredient: MEZLOCILLIN SODIUM · FDA Application: 050549 ·
First Report: 19841026 · Latest Report: 20200101
What Are the Most Common MEZLOCILLIN Side Effects?
#1 Most Reported
Pruritus
13 reports (54.2%)
#2 Most Reported
Rash
12 reports (50.0%)
#3 Most Reported
Toxic epidermal necrolysis
11 reports (45.8%)
All MEZLOCILLIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pruritus | 13 | 54.2% | 10 | 11 |
| Rash | 12 | 50.0% | 9 | 10 |
| Blister | 11 | 45.8% | 10 | 11 |
| Stevens-johnson syndrome | 11 | 45.8% | 10 | 11 |
| Toxic epidermal necrolysis | 11 | 45.8% | 10 | 11 |
| Cardiac arrest | 10 | 41.7% | 10 | 10 |
| Circulatory collapse | 10 | 41.7% | 10 | 10 |
| Conjunctivitis | 10 | 41.7% | 10 | 10 |
| Lip erosion | 10 | 41.7% | 10 | 10 |
| Skin exfoliation | 10 | 41.7% | 10 | 10 |
| Skin lesion | 10 | 41.7% | 10 | 10 |
Who Reports MEZLOCILLIN Side Effects? Age & Gender Data
Gender: 90.9% female, 9.1% male. Average age: 49.4 years. Most reports from: CN. View detailed demographics →
Is MEZLOCILLIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 9 | 9 | 9 |
| 2013 | 2 | 0 | 0 |
| 2014 | 2 | 0 | 0 |
| 2015 | 2 | 0 | 1 |
| 2020 | 1 | 0 | 0 |
What Is MEZLOCILLIN Used For?
| Indication | Reports |
|---|---|
| Cholangitis | 9 |
Official FDA Label for MEZLOCILLIN
Official prescribing information from the FDA-approved drug label.